Circulating makorin ring finger protein 3 levels decline in boys before the clinical onset of puberty

Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inh...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of endocrinology Vol. 174; no. 6; pp. 785 - 790
Main Authors Varimo, Tero, Dunkel, Leo, Vaaralahti, Kirsi, Miettinen, Päivi J, Hero, Matti, Raivio, Taneli
Format Journal Article
LanguageEnglish
Published England Bioscientifica Ltd 01.06.2016
Oxford University Press
Subjects
Online AccessGet full text
ISSN0804-4643
1479-683X
1479-683X
DOI10.1530/EJE-15-1193

Cover

Abstract Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels. Design Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1–14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years. Methods We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using measures. Results Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (–2931±2750 pg/mL per year) and plateaued thereafter (–560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (–782±3190 vs –2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=–0.5, P<0.01), testosterone (r=–0.6, P<0.01), and inhibin B (r=–0.44, P<0.05) (n=26). Conclusion Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty.
AbstractList Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic-pituitary-gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels. Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1-14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years. We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using summary measures. Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (-2931±2750 pg/mL per year) and plateaued thereafter (-560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (-782±3190 vs -2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=-0.5, P<0.01), testosterone (r=-0.6, P<0.01), and inhibin B (r=-0.44, P<0.05) (n=26). Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty.
Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels. Design Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1–14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years. Methods We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using summary measures. Results Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (–2931±2750 pg/mL per year) and plateaued thereafter (–560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (–782±3190 vs –2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=–0.5, P<0.01), testosterone (r=–0.6, P<0.01), and inhibin B (r=–0.44, P<0.05) (n=26). Conclusion Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty.
Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels. Design Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1–14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years. Methods We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using measures. Results Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (–2931±2750 pg/mL per year) and plateaued thereafter (–560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (–782±3190 vs –2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=–0.5, P<0.01), testosterone (r=–0.6, P<0.01), and inhibin B (r=–0.44, P<0.05) (n=26). Conclusion Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty.
Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic-pituitary-gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels.OBJECTIVEMakorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic-pituitary-gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels.Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1-14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years.DESIGNLongitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1-14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years.We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using summary measures.METHODSWe analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using summary measures.Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (-2931±2750 pg/mL per year) and plateaued thereafter (-560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (-782±3190 vs -2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=-0.5, P<0.01), testosterone (r=-0.6, P<0.01), and inhibin B (r=-0.44, P<0.05) (n=26).RESULTSSerum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (-2931±2750 pg/mL per year) and plateaued thereafter (-560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (-782±3190 vs -2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=-0.5, P<0.01), testosterone (r=-0.6, P<0.01), and inhibin B (r=-0.44, P<0.05) (n=26).Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty.CONCLUSIONPeripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty.
Author Varimo, Tero
Hero, Matti
Raivio, Taneli
Miettinen, Päivi J
Vaaralahti, Kirsi
Dunkel, Leo
AuthorAffiliation William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Hospital, University of Helsinki and Helsinki UniversityFinland
Faculty of Medicine/ Physiology, University of Helsinki, Helsinki, Finland
Research Programs Unit, Molecular Neurology, and Biomedicum Stem Cell Center, University of Helsinki, Finland
AuthorAffiliation_xml – name: Research Programs Unit, Molecular Neurology, and Biomedicum Stem Cell Center, University of Helsinki, Finland
– name: William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– name: Hospital, University of Helsinki and Helsinki UniversityFinland
– name: Faculty of Medicine/ Physiology, University of Helsinki, Helsinki, Finland
Author_xml – sequence: 1
  givenname: Tero
  surname: Varimo
  fullname: Varimo, Tero
  organization: Hospital, University of Helsinki and Helsinki UniversityFinland
– sequence: 2
  givenname: Leo
  surname: Dunkel
  fullname: Dunkel, Leo
  organization: William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
– sequence: 3
  givenname: Kirsi
  surname: Vaaralahti
  fullname: Vaaralahti, Kirsi
  organization: Faculty of Medicine/ Physiology, University of Helsinki, Helsinki, Finland
– sequence: 4
  givenname: Päivi J
  surname: Miettinen
  fullname: Miettinen, Päivi J
  organization: Research Programs Unit, Molecular Neurology, and Biomedicum Stem Cell Center, University of Helsinki, Finland
– sequence: 5
  givenname: Matti
  surname: Hero
  fullname: Hero, Matti
  organization: Hospital, University of Helsinki and Helsinki UniversityFinland
– sequence: 6
  givenname: Taneli
  surname: Raivio
  fullname: Raivio, Taneli
  email: taneli.raivio@helsinki.fi
  organization: Faculty of Medicine/ Physiology, University of Helsinki, Helsinki, Finland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27025240$$D View this record in MEDLINE/PubMed
BookMark eNp9kU2LFDEQhoOsuLOrJ-8S8CJIa-Wju6ePMowfy8JeFLyFJF3RrJlkTNLC_PvNsLOXRfaSVFWet1K8dUHOYopIyGsGH1gv4OP2atuxvmNsEs_Iislx6oa1-HlGVrAG2clBinNyUcotAGsxvCDnfATecwkrghuf7RJ09fEX3ek_KftI8zFx7cBM9zlVbDVBA_7DUOiMNviItNVMOhRq0KWMtP5GenzwVgeaYsFKk6P7xWCuh5fkudOh4KvTfUl-fN5-33ztrm--fNt8uu6M6KfamdmuJZu54dMwz8CNYHwaJ8agH8EyI6UeJ1jPTkxCGyecQNPDgEI7BlYbcUne3fdtU_9dsFS188ViCDpiWopiTQ4cxDg09O0j9DYtObbpFAfJx4GB4I16c6IWs8NZ7bPf6XxQDwY2gN0DNqdSMjplfW1upliz9kExUMclqbakFqjjkprm_SPNQ9v_06cfjE_FeozVu2byk5o744ChOw
CitedBy_id crossref_primary_10_1159_000493134
crossref_primary_10_1007_s12020_017_1281_x
crossref_primary_10_4274_jcrpe_galenos_2023_2022_6_6
crossref_primary_10_3389_fendo_2019_00048
crossref_primary_10_1515_jpem_2020_0331
crossref_primary_10_1172_JCI139586
crossref_primary_10_1016_j_beem_2019_101316
Cites_doi 10.1038/nrendo.2015.112
10.1056/NEJMoa1302160
10.1136/bmj.300.6719.230
10.1093/humrep/deu256
10.1038/pr.2015.159
10.1111/cen.12851
10.1136/adc.45.239.13
10.1210/jc.2014-4462
10.1210/jc.2013-3126
10.1210/jc.2002-021954
10.1111/j.0954-6820.1952.tb13395.x
10.1126/science.1260419
10.1016/B978-0-12-397175-3.00032-6
10.1210/jc.2005-1392
10.1530/JME-14-0315
10.1111/cen.13027
10.1530/EJE-15-0488
ContentType Journal Article
Copyright 2016 European Society of Endocrinology
2016 European Society of Endocrinology.
Copyright BioScientifica Ltd. Jun 2016
Copyright_xml – notice: 2016 European Society of Endocrinology
– notice: 2016 European Society of Endocrinology.
– notice: Copyright BioScientifica Ltd. Jun 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
DOI 10.1530/EJE-15-1193
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate Circulating MKRN3 levels in peripubertal boys
EISSN 1479-683X
EndPage 790
ExternalDocumentID 27025240
10_1530_EJE_15_1193
Genre Randomized Controlled Trial
Journal Article
GroupedDBID ---
-~X
.55
.GJ
0R~
169
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
5WD
AABZA
AACZT
AAPGJ
AAPXW
AAVAP
AAWDT
ABLYK
ABOCM
ABPQP
ABPTD
ABPTK
ABSGY
ABSQV
ABWST
ABXZS
ACFRR
ACGFO
ACNCT
ACPRK
ACUTJ
ADBBV
ADDZX
ADIPN
ADQBN
ADVEK
AENEX
AEQTP
AFFNX
AFGWE
AFHIN
AFYAG
AGQXC
AGUTN
AI.
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALXQX
ANFBD
APJGH
BAWUL
BCRHZ
BTFSW
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
EMOBN
F9R
GX1
HZ~
IL9
INIJC
J5H
KOP
KQ8
L7B
O9-
OAUYM
OBFPC
OBOKY
OCZFY
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
RHF
ROX
SJN
TBS
TCN
TEORI
TMA
TR2
VH1
W8F
WOQ
X7M
ZA5
ZGI
ZXP
AARHZ
AAUAY
AAYXX
ABDFA
ABEJV
ABGNP
ABIME
ABJNI
ABMNT
ABNHQ
ABPIB
ABQNK
ABVGC
ABXVV
ADGKP
ADMTO
ADNBA
ADVOB
AEMQT
AFXAL
AHGBF
AHMMS
AJBYB
AJNCP
ATGXG
CITATION
H13
NU-
AGORE
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
ID FETCH-LOGICAL-b359t-bdc841d2b296dd02b312979110570c1b44a7908df393abf3f3eb506e3af10cab3
ISSN 0804-4643
1479-683X
IngestDate Sat Sep 27 21:12:32 EDT 2025
Fri Jul 25 05:02:40 EDT 2025
Mon Jul 21 06:06:41 EDT 2025
Wed Oct 01 04:51:13 EDT 2025
Thu Apr 24 22:57:57 EDT 2025
Sun Jan 07 07:18:52 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License 2016 European Society of Endocrinology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b359t-bdc841d2b296dd02b312979110570c1b44a7908df393abf3f3eb506e3af10cab3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink http://dx.doi.org/10.1530/EJE-15-1193
PMID 27025240
PQID 2042761032
PQPubID 2049084
PageCount 6
ParticipantIDs proquest_miscellaneous_1790020376
proquest_journals_2042761032
pubmed_primary_27025240
crossref_citationtrail_10_1530_EJE_15_1193
crossref_primary_10_1530_EJE_15_1193
bioscientifica_primary_10_1530_EJE_15_1193
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20160600
2016-06-00
2016-Jun
20160601
PublicationDateYYYYMMDD 2016-06-01
PublicationDate_xml – month: 06
  year: 2016
  text: 20160600
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bristol
PublicationTitle European journal of endocrinology
PublicationTitleAlternate Eur J Endocrinol
PublicationYear 2016
Publisher Bioscientifica Ltd
Oxford University Press
Publisher_xml – name: Bioscientifica Ltd
– name: Oxford University Press
References Kansakoski J (2016051718591929000_174.6.785.3) 2015; 78
2016051718591929000_174.6.785.6
2016051718591929000_174.6.785.7
2016051718591929000_174.6.785.8
2016051718591929000_174.6.785.1
2016051718591929000_174.6.785.2
2016051718591929000_174.6.785.4
2016051718591929000_174.6.785.16
2016051718591929000_174.6.785.14
2016051718591929000_174.6.785.15
2016051718591929000_174.6.785.9
2016051718591929000_174.6.785.13
2016051718591929000_174.6.785.11
Boehm (2016051718591929000_174.6.785.17) 2015; 11
Simon (2016051718591929000_174.6.785.12) 2015; 174
Hagen (2016051718591929000_174.6.785.5) 2015; 100
Hansen (2016051718591929000_174.6.785.10) 1952; 266
References_xml – volume: 11
  start-page: 547
  year: 2015
  ident: 2016051718591929000_174.6.785.17
  article-title: Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism – pathogenesis, diagnosis and treatment
  publication-title: Nature Reviews Endocrinology
  doi: 10.1038/nrendo.2015.112
– ident: 2016051718591929000_174.6.785.1
  doi: 10.1056/NEJMoa1302160
– ident: 2016051718591929000_174.6.785.11
  doi: 10.1136/bmj.300.6719.230
– ident: 2016051718591929000_174.6.785.14
  doi: 10.1093/humrep/deu256
– volume: 78
  start-page: 709
  year: 2015
  ident: 2016051718591929000_174.6.785.3
  article-title: A missense mutation in MKRN3 in a Danish girl with central precocious puberty and her brother with early puberty
  publication-title: Pediatric Research
  doi: 10.1038/pr.2015.159
– ident: 2016051718591929000_174.6.785.6
  doi: 10.1111/cen.12851
– ident: 2016051718591929000_174.6.785.9
  doi: 10.1136/adc.45.239.13
– volume: 100
  start-page: 1920
  year: 2015
  ident: 2016051718591929000_174.6.785.5
  article-title: Circulating MKRN3 levels decline prior to pubertal onset and through puberty: a longitudinal study of healthy girls
  publication-title: Journal of Clinical Endocrinology and Metabolism
  doi: 10.1210/jc.2014-4462
– ident: 2016051718591929000_174.6.785.15
  doi: 10.1210/jc.2013-3126
– ident: 2016051718591929000_174.6.785.16
  doi: 10.1210/jc.2002-021954
– volume: 266
  start-page: 457
  year: 1952
  ident: 2016051718591929000_174.6.785.10
  article-title: Clinical measurements of the testes in boys and men
  publication-title: Acta Medica Scandinavica Supplementum
  doi: 10.1111/j.0954-6820.1952.tb13395.x
– ident: 2016051718591929000_174.6.785.4
  doi: 10.1126/science.1260419
– ident: 2016051718591929000_174.6.785.13
  doi: 10.1016/B978-0-12-397175-3.00032-6
– ident: 2016051718591929000_174.6.785.8
  doi: 10.1210/jc.2005-1392
– ident: 2016051718591929000_174.6.785.2
  doi: 10.1530/JME-14-0315
– ident: 2016051718591929000_174.6.785.7
  doi: 10.1111/cen.13027
– volume: 174
  start-page: 1
  year: 2015
  ident: 2016051718591929000_174.6.785.12
  article-title: Mutations in the maternally imprinted gene MKRN3 are common in familial central precocious puberty
  publication-title: European Journal of Endocrinology
  doi: 10.1530/EJE-15-0488
SSID ssj0016430
Score 2.2323222
Snippet Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to...
Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic-pituitary-gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset...
SourceID proquest
pubmed
crossref
bioscientifica
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 785
SubjectTerms Adolescent
Aromatase
Aromatase Inhibitors - therapeutic use
Biochemical markers
Child
Clinical Study
Clinical trials
Double-Blind Method
Growth Disorders - blood
Growth Disorders - drug therapy
Humans
Hypothalamus
Inhibin
Letrozole
Male
Nitriles - therapeutic use
Pituitary
Puberty
Puberty - blood
Ribonucleoproteins - blood
Testosterone
Treatment Outcome
Triazoles - therapeutic use
Title Circulating makorin ring finger protein 3 levels decline in boys before the clinical onset of puberty
URI http://dx.doi.org/10.1530/EJE-15-1193
https://www.ncbi.nlm.nih.gov/pubmed/27025240
https://www.proquest.com/docview/2042761032
https://www.proquest.com/docview/1790020376
Volume 174
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1479-683X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0016430
  issn: 0804-4643
  databaseCode: KQ8
  dateStart: 19480601
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1479-683X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0016430
  issn: 0804-4643
  databaseCode: KQ8
  dateStart: 19970701
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1479-683X
  dateEnd: 20241002
  omitProxy: true
  ssIdentifier: ssj0016430
  issn: 0804-4643
  databaseCode: GX1
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbKkBBIINj4URjISNMeqDKSOHaSx2nqNI1ugNSivkV24ohqazL6A2m88o9zZ7tpCx0avESR68ZRvi-Xs_3dHSF7CU_iRPnS40UZelGcMC_VpfQCJksGd85jhQv6Z-fiZBCdDvmw1fq5olqaz9RB_mNjXMn_oAptgCtGyf4Dss1FoQHOAV84AsJwvBXGR6NJbspvwXR_LC9QS9cxerrSphc0SRigjXUuURs07RQ6N24ltKn6etpRGnxWbZzPJkQS5dVGHgBIYeLdG9funR-rq6IG07O-Pv8FpuBjswrb15N6xVu-sKqAnq6XXSUGc351ugJcRWlYMNIoy7aW8ZPZ049G30duK8utVQRiqaly5jWKU08kpgIwfH02tC1ssi3d48i3amFjW-HnD8vPGUolu6ddL-BeENiyi-v5tc8_ZseDXi_rd4f9_atvHpYewy16V4flDrkbxkJgGYwPn5dbUeCymajaxW26IE8Y7_3KaA_IQzWy6UeNxus3P-eGyYtxYvqPySM3-6CHlkpPSEtX22TnsJKzenxN96nRAxsgt8m9Mye72CF6hWjUEY0i0aglGnVEo4xaolFHNAptSDRqiUaBaHRBNGqIRuuSOqI9JYPjbv_oxHP1OTzFeDrzVJEnUVCEKkxFUfihYuA8xvD1hDmAnwcqimSc-klRspRJVTJ4-RX3hQYzEPi5VOwZ2arqSr8gVKg0h4-zkiUmkpZBooJcc8m1ZnlSiLJN3q0_3uzKJmPJcBILWGSABZxkiAV0Xjz6LHeZ7rHgyuXmzntN579ec3eBYeZesWkWYqEagSkp2-Rt8zPYZ9x0k5Wu59MMM-Dhbn8s2uS5xb4ZB2NBObjUL2_x71fk_vKN2iVbs8lcvwZ_eKbeGL7-AkWvuXI
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circulating+makorin+ring+finger+protein+3+levels+decline+in+boys+before+the+clinical+onset+of+puberty&rft.jtitle=European+journal+of+endocrinology&rft.au=Varimo%2C+Tero&rft.au=Dunkel%2C+Leo&rft.au=Vaaralahti%2C+Kirsi&rft.au=Miettinen%2C+P%C3%A4ivi+J&rft.date=2016-06-01&rft.issn=1479-683X&rft.eissn=1479-683X&rft.volume=174&rft.issue=6&rft.spage=785&rft_id=info:doi/10.1530%2FEJE-15-1193&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0804-4643&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0804-4643&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0804-4643&client=summon